Literature DB >> 20922354

[Anesthesia with neuromuscular diseases].

M U Gerbershagen1, F Wappler.   

Abstract

Among the neuromuscular diseases (NMDs) over 800 individual entities have been identified. The vast majority of these diseases occur very seldom but all NMDs together add up to a prevalence of 1:1,500. Accordingly the conclusion "seldom diseases are common" seems to be appropriate. The scope of NMDs is very wide varying from the affection of single muscle groups to the complete musculature, from slowly progressive to fulminant progressive forms, from perinatal to the adult manifestation as well as number, course and character of associated comorbidities. Due to the wide heterogeneity concerning NMDs it is of great importance for anesthesiologists to be knowledgeable on relevant comorbidities as well as indications and contraindications for the various anesthetics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20922354     DOI: 10.1007/s00101-010-1794-7

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  20 in total

1.  Safety of succinylcholine in myasthenia gravis.

Authors:  Richard Levitan
Journal:  Ann Emerg Med       Date:  2005-02       Impact factor: 5.721

2.  [Anaesthesia associated rhabdomyolysis. Diagnosis, therapy and prevention of skeletal muscle breakdown].

Authors:  Jan Karl Schütte; Mark Ulrich Gerbershagen; Frank Wappler
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2006 Jul-Aug       Impact factor: 0.698

Review 3.  Cardiac manifestations of neuromuscular disorders in children.

Authors:  Daphne T Hsu
Journal:  Paediatr Respir Rev       Date:  2009-11-18       Impact factor: 2.726

4.  Pulmonary complications of neuromuscular disease: a respiratory mechanics perspective.

Authors:  Julian Allen
Journal:  Paediatr Respir Rev       Date:  2009-12-02       Impact factor: 2.726

5.  Perioperative cardiac arrest in a patient with previously undiagnosed Becker's muscular dystrophy after isoflurane anaesthesia for elective surgery.

Authors:  T C Poole; T Y J Lim; J Buck; A S Kong
Journal:  Br J Anaesth       Date:  2010-02-26       Impact factor: 9.166

6.  Onset and duration of rocuronium-induced neuromuscular blockade in patients with Duchenne muscular dystrophy.

Authors:  Stefanie Wick; Tino Muenster; Joachim Schmidt; Juergen Forst; Hubert J Schmitt
Journal:  Anesthesiology       Date:  2005-05       Impact factor: 7.892

Review 7.  Malignant hyperthermia, coexisting disorders, and enzymopathies: risks and management options.

Authors:  Joan Benca; Kirk Hogan
Journal:  Anesth Analg       Date:  2009-10       Impact factor: 5.108

Review 8.  Duchenne muscular dystrophy: an old anesthesia problem revisited.

Authors:  Jason Hayes; Francis Veyckemans; Bruno Bissonnette
Journal:  Paediatr Anaesth       Date:  2008-02       Impact factor: 2.556

9.  The use of sugammadex in a patient with myasthenia gravis.

Authors:  C Unterbuchner; H Fink; M Blobner
Journal:  Anaesthesia       Date:  2010-01-23       Impact factor: 6.955

10.  Worsening of neurologic symptoms after epidural anesthesia for labor in a Guillain-Barré patient.

Authors:  Sandrine Wiertlewski; Armelle Magot; Sophie Drapier; Jean-Marc Malinovsky; Yann Péréon
Journal:  Anesth Analg       Date:  2004-03       Impact factor: 5.108

View more
  1 in total

Review 1.  Anesthetic management of a patient with limb-girdle muscular dystrophy 2B:CARE-compliant case report and literature review.

Authors:  X Q Cao; K Joypaul; F Cao; L L Gui; J T Hu; W Mei
Journal:  BMC Anesthesiol       Date:  2019-08-17       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.